Pharmaceutical Commerce
JULY 31, 2025
14 This is in the midst of various companies—such as Regeneron, Roche, Merck, and ThermoFisher—reshoring production to the United States in order to avoid paying these hefty tariffs—a process that can take years if the proper infrastructure is not already put in place. Subscribe Now!
Pharmaceutical Commerce
JULY 29, 2025
1 The EU will also be investing $600 billion in the US and purchasing $750 billion worth of US energy exports through the year 2028. Deal averts 30% tariff threat while triggering pharma sector concerns This development comes as an Aug.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 10, 2025
Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028, RFK Jr wrote. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.
Putting Patients First Blog
OCTOBER 31, 2024
652 and HR 2630 ) would ensure that employer health plans offer a medically reasonable step therapy exceptions process, intended to help patients more quickly access effective treatments. Introduced by Senator Lisa Murkowski (R-AK) and Representative Brad Wenstrup (R-OH), the bipartisan Safe Step Act ( S.652 For instance, Section 203 of S.3430
Putting Patients First Blog
NOVEMBER 12, 2024
General Support for CMS Proposals The NHC commends CMS for its ongoing commitment to advancing health equity, improving access to care, ensuring program integrity, and maintaining affordability through Marketplace coverage. Copay Assistance and Drug Coverage in Large Group Plans Accumulator Adjustment Programs and Cost Sharing.
Putting Patients First Blog
FEBRUARY 11, 2025
3 Establishing a feedback loop with stakeholders during this monitoring process will provide additional safeguards against adverse effects. Engaging stakeholders in transparent decision-making processes is critical to the success of risk adjustment model updates.
Expert insights. Personalized for you.
Let's personalize your content